L-arginine is a type of α-amino acid. The L-form is one of the 20 most common natural amino acids. A nonessential amino acid in human, L-Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in dietary supplements, infusions and infant formulas.
Major factors driving growth of this market include the application of biological fermentation technology, which enabled the production of arginine improved a lot, rising care awareness and increasing disposable income in emerging economies, However, high cost of instruments, lack of production technology especially in emerging economies, and lack of laboratory technicians are expected to restrain the growth of this market.
The L-Arginine industry concentration is not high; there are more than one hundreds manufacturers in the world, and high-end products mainly from Eastern Asia and Western European.
Global giant manufactures mainly distributed in Eastern Asia and E.U. The manufacturers in Japan have a long history and unshakable status in this field. Manufacturers such as Ajinomoto & KYOWA have relative higher level of product\'s quality. In Germany, EVONIK leads the technology development. Most of Chinese manufactures locate in Hebei, Shandong and Zhejiang province.
Many companies have several plants, usually locate in the place close to aimed consumption region. There are international companies set up factories in China either, such as CJ whose plant is located at Shandong province.
We tend to believe this industry becomes more and more mature, and the consumption increasing rate will show a smooth curve.
The report offers detailed coverage of L-Arginine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading L-Arginine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global L-Arginine market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global L-Arginine market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Ajinomoto group
KYOWA
Evonik
CJ
Daesang
Jurui Biotechnology
Jingjing
Jinghai Amino Acid
Jiahe Biotech
SHINE STAR
Xingyu Technology
Longtengbiotech
JIRONG PHARM
At the same time, we classify L-Arginine according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Food Grade
Pharma Grade
Market by Application
Supplements & Nutrition
Pharmaceuticals
Cosmetics
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the L-Arginine market for the forecast period 2021 - 2025?
• What are the driving forces in the L-Arginine market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the L-Arginine industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?